Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. (Q34167551)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

title

Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

0 references

0 references

1 reference

Lara A Ray

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

Dara G Ghahremani

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

Karen Miotto

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

Arthur Brody

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

publication date

15 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

volume

231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

3843-3853

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

Nicotine interactions with low-dose alcohol: pharmacological influences on smoking and drinking motivation.

14 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Tobacco quitlines need to assess and intervene with callers' hazardous drinking

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Varenicline decreases alcohol consumption in heavy-drinking smokers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Varenicline effects on craving, cue reactivity, and smoking reward

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

The subjective effects of alcohol-tobacco co-use: an ecological momentary assessment investigation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Nicotine receptor partial agonists for smoking cessation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

A preliminary investigation of varenicline for heavy drinking smokers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Alcohol use and initial smoking lapses among heavy drinkers in smoking cessation treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Varenicline reduces alcohol self-administration in heavy-drinking smokers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Varenicline: progress in smoking cessation treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Smoking kills (alcoholics)! shouldn't we do something about it?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Oral varenicline for smoking cessation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Non-treatment-seeking heavy drinkers: effects of chronic cigarette smoking on brain structure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Standardization of alcohol calculations in research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Nicotine addiction and comorbidity with alcohol abuse and mental illness

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Medication screening for smoking cessation: a proposal for new methodologies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Epidemiologic analysis of alcohol and tobacco use.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking history

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Predictors of smoking cessation in a cohort of adult smokers followed for five years

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Effect of naltrexone on alcohol "high" in alcoholics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Naltrexone in the treatment of alcohol dependence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking

5 July 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Naltrexone augments the effects of nicotine replacement therapy in female smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

On the Interpretation of χ 2 from Contingency Tables, and the Calculation of P

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Genes, time to first cigarette and nicotine dependence in a general population sample of young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Naltrexone and nicotine patch smoking cessation: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Naltrexone improves outcome of a controlled drinking program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

A double-blind study evaluating the long-term safety of varenicline for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-014-3519-0

The effects of varenicline on stress-induced and cue-induced craving for cigarettes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161630

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

28 October 2018

1 reference

12 December 2020

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation

1 reference

12 December 2020

The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research

1 reference

12 December 2020

SAFTEE: a technique for the systematic assessment of side effects in clinical trials

1 reference

12 December 2020

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

12 December 2020

Interrater agreement and intraclass reliability measures of SAFTEE in psychopharmacologic clinical trials

1 reference

12 December 2020

Development and validation of the Wisconsin Smoking Withdrawal Scale

1 reference

12 December 2020

Drinking as a risk factor for sustained smoking

1 reference

12 December 2020

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse

1 reference

12 December 2020

10.1007/S00213-014-3519-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

14 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24733235 AND SRC:MED&resulttype=core&format=json

14 March 2020

PubMed publication ID

24733235

1 reference